Literature DB >> 16787519

Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients.

Masayuki Baba, Ken-ichi Kimura, Toshihiro Suda, Soroku Yagihashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16787519     DOI： 10.1111/j.1085-9489.2006.00085.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN： 1085-9489            Impact factor:   3.494


× No keyword cloud information.
  3 in total

1.  The Relationship between Peripheral Nerve Conduction Velocity and Ophthalmological Findings in Type 2 Diabetes Patients with Early Diabetic Retinopathy.

Authors:  Azusa Ito; Hiroshi Kunikata; Masayuki Yasuda; Shojiro Sawada; Keiichi Kondo; Chihiro Satake; Kazuki Hashimoto; Naoko Aizawa; Hideki Katagiri; Toru Nakazawa
Journal:  J Ophthalmol       Date:  2018-02-20       Impact factor: 1.909

2.  Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats.

Authors:  Bai-Bing Yang; Zhi-Wei Hong; Zheng Zhang; Wen Yu; Tao Song; Lei-Lei Zhu; He-Song Jiang; Guo-Tao Chen; Yun Chen; Yu-Tian Dai
Journal:  Int J Impot Res       Date:  2018-09-13       Impact factor: 2.896

3.  Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose.

Authors:  Zubeyir Elmazoglu; Marta Soltesova Prnova; Abel Santamaria; Milan Stefek; Cimen Karasu
Journal:  Neurotox Res       Date:  2020-11-04       Impact factor: 3.911
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.